Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 3 boards, counting each seat separately. Longest: Forum Markets Incorporated, 3 years.
Forum Markets Incorporated
Director
Beeline Holdings Inc.
Director
Endovia Health Sciences Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 8, 2026 | Beeline Holdings Inc. | Grant or award | +50,000 | — | — |
| May 28, 2026 | Beeline Holdings Inc. | Grant or award | +10,000 | — | — |
| May 22, 2026 | Pelthos Therapeutics Inc. | Sold back to the company | −13,947 | — | — |
| May 22, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −1,500 | $26.84 | $40,260 |
| Dec 16, 2025 | Beeline Holdings Inc. | Grant or award | +30,000 | — | — |
| Oct 2, 2025 | Beeline Holdings Inc. | Grant or award | +40,000 | — | — |
| Jul 1, 2025 | Pelthos Therapeutics Inc. | Derivative conversion | +10,000 | $10.00 | $100,000 |
| Sep 13, 2024 | Pelthos Therapeutics Inc. | Open-market purchase | +3,500 | $0.97 | $3,395 |
| Sep 12, 2024 | Pelthos Therapeutics Inc. | Open-market purchase | +1,700 | $0.97 | $1,649 |
| Sep 11, 2024 | Pelthos Therapeutics Inc. | Open-market purchase | +5,500 | $0.94 | $5,170 |
| Sep 10, 2024 | Pelthos Therapeutics Inc. | Open-market purchase | +6,500 | $0.89 | $5,785 |
| Jun 28, 2024 | Pelthos Therapeutics Inc. | Gift | −5,000 | — | — |
| Jun 28, 2024 | Pelthos Therapeutics Inc. | Gift | −15,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.